Compass Therapeutics Inc.
(CMPX)
undefined
undefined%
At close: undefined
1.46
0.34%
After-hours Dec 13, 2024, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -42.49M | -39.23M | -82.18M | -29.50M | -34.74M | -38.29M |
| Depreciation & Amortization | 1.89M | 1.90M | 1.62M | 2.40M | 2.12M | 1.92M |
| Stock-Based Compensation | 6.12M | 5.33M | 4.03M | 4.02M | 915.00K | 656.00K |
| Other Working Capital | -3.62M | -3.78M | 6.44M | -4.03M | 844.00K | 1.18M |
| Other Non-Cash Items | 5.97M | -871.00K | 41.00K | -960.00K | 116.00K | 121.00K |
| Deferred Income Tax | - | - | 50.58M | 837.00K | 109.00K | -261.00K |
| Change in Working Capital | -2.91M | -1.26M | 6.25M | -3.60M | -257.00K | 2.17M |
| Operating Cash Flow | -40.62M | -34.13M | -19.67M | -26.80M | -31.74M | -33.68M |
| Capital Expenditures | -30.00K | -212.00K | -1.57M | -106.00K | -466.00K | -2.02M |
| Acquisitions | - | 176.00K | 116.00K | 144.00K | - | - |
| Purchase of Investments | -155.42M | -200.12M | - | - | - | - |
| Sales Maturities Of Investments | 182.41M | 48.95M | - | - | - | - |
| Other Investing Acitivies | 27.00K | -150.99K | -318.00K | 144.00 | - | - |
| Investing Cash Flow | 26.96M | -151.20M | -1.77M | 38.00K | -466.00K | -2.02M |
| Debt Repayment | - | - | - | - | - | - |
| Common Stock Repurchased | -159 | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - |
| Other Financial Acitivies | -159.00K | -480.00K | -281.00K | -6.32M | 37.63K | 64.03M |
| Financial Cash Flow | 2.94M | 75.76M | 118.61M | 48.54M | 37.63K | 64.03M |
| Net Cash Flow | -10.72M | -109.57M | 97.17M | 21.77M | -32.21M | 28.33M |
| Free Cash Flow | -40.65M | -34.34M | -21.23M | -26.91M | -32.21M | -35.70M |